Publisher Correction: Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma

Sci Rep. 2018 Nov 23;8(1):17449. doi: 10.1038/s41598-018-36016-9.

Jessica E Sagers^{1

2

3}, Adam S Brown^{4

3}, Sasa Vasilijic^{1

5}, Rebecca M Lewis^{1

5}, Mehmet I Sahin^{1

5}, Lukas D Landegger^{1

5

6}, Roy H Perlis⁷, Isaac S Kohane⁴, D Bradley Welling^{1

5}, Chirag J Patel⁴, Konstantina M Stankovic^{8

9

10}

¹ Eaton-Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and Ear, Boston, MA, 02114, USA.
² Program in Speech and Hearing Bioscience and Technology, Harvard Medical School, Boston, MA, 02115, USA.
³ Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA, 02115, USA.
⁴ Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
⁵ Department of Otolaryngology, Harvard Medical School, Boston, MA, 02114, USA.
⁶ Department of Otolaryngology, Vienna General Hospital, Medical University of Vienna, Vienna, 1090, Austria.
⁷ Center for Experimental Drugs and Diagnostics, Department of Psychiatry and Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
⁸ Eaton-Peabody Laboratories, Department of Otolaryngology, Massachusetts Eye and Ear, Boston, MA, 02114, USA. konstantina_stankovic@meei.harvard.edu.
⁹ Program in Speech and Hearing Bioscience and Technology, Harvard Medical School, Boston, MA, 02115, USA. konstantina_stankovic@meei.harvard.edu.
¹⁰ Department of Otolaryngology, Harvard Medical School, Boston, MA, 02114, USA. konstantina_stankovic@meei.harvard.edu.

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.